Projects
Librexia AF is a randomized study to evaluate the efficacy and safety of mlivexian versus apixaban in atrial fibrillation.
Project Duration
2024 - Ongoing
Project Lead
National Leader: Dr Denis Xavier
Authors
Dr E. Tan
Project Status
ongoing
Project Type
Type 1